Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H21ClN2O2 |
| Molecular Weight | 284.782 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCNC(=O)COC1=CC=C(Cl)C=C1
InChI
InChIKey=UORGKWWJEQDTGX-UHFFFAOYSA-N
InChI=1S/C14H21ClN2O2/c1-3-17(4-2)10-9-16-14(18)11-19-13-7-5-12(15)6-8-13/h5-8H,3-4,9-11H2,1-2H3,(H,16,18)
| Molecular Formula | C14H21ClN2O2 |
| Molecular Weight | 284.782 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/6241720Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/122234
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6241720
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/122234
Clofexamide (or Amichlophene) is an antidepressant that was a component of the drug combination clofezone, the other being the nonsteroidal anti-inflammatory drug (NSAID) phenylbutazone. Clofezone potentiated hexobarbital-induced sleep in mice, prevented tolerance to morphine, increased uterine motility in rabbits, inhibited Pentetrazole seizure and toxic effects of bacterial polysaccharides in mice, inhibited the action potential of rat sciatic nerves, but had no significant effect on blood pressure, heart function, blood coagulation, hemolysis, respiration, or intestinal motility in rabbits. Clofezone was used to treat joint and muscular pain but is not marketed anymore.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6241720
0.4 g phenylbutazone or 0.8 g clofezone
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:33:46 GMT 2025
by
admin
on
Mon Mar 31 18:33:46 GMT 2025
|
| Record UNII |
071P4J77HF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C77345
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106515
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
21255
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | RxNorm | ||
|
28554
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
SUB06704MIG
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
Clofexamide
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
100000084333
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
214-951-6
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
C004687
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
071P4J77HF
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
DTXSID6046424
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
1640
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY | |||
|
1223-36-5
Created by
admin on Mon Mar 31 18:33:46 GMT 2025 , Edited by admin on Mon Mar 31 18:33:46 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |